Quality‐of‐life scores improve after 96 weeks of PEG‐IFNa‐2a treatment of hepatitis D: An analysis of the HIDIT‐II trial - Dinkelborg, K; Kahlhöfer, J; Dörge, P (Liver Int, 2023)